Alcohol Dependency Study: Combining Medication Treatment for Alcoholism
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn whether ondansetron and topiramate either alone or in
combination is safe and effective in the treatment of alcohol dependence. This 13 week
out-patient clinical trial is randomized, double-blind, and placebo-controlled. There are
post-study follow up visits 1, 2 and 3 months after the end of the study. Participants will
receive ondansetron and topiramate either alone or in combination or a placebo coupled with
psychotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Bankole Johnson
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)